HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MI192

selective HDAC2-3 inhibitor
Also Known As:
HDAC inhibitor MI192; Histone Deacetylase Inhibitor MI192; N-(2-Aminophenyl)-4-((3,4-dihydro-4-methylene-1-oxo-2(1H)-isoquinolinyl)methyl)benzamide
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Grigg, Ronald: 2 articles (12/2015 - 02/2012)
2. Al-Griw, Mohamed A: 1 article (07/2021)
3. Bennour, Emad M: 1 article (07/2021)
4. Elhensheri, Mohamed M: 1 article (07/2021)
5. Shmela, Mansur E: 1 article (07/2021)
6. Demyanenko, S V: 1 article (01/2020)
7. Nikul, V V: 1 article (01/2020)
8. Uzdensky, A B: 1 article (01/2020)
9. Dorfman, Robert Gregory: 1 article (01/2017)
10. Huang, Shan: 1 article (01/2017)

Related Diseases

1. Brain Injuries (Brain Injury)
2. Stroke (Strokes)
3. Cholangiocarcinoma
4. Prostatic Neoplasms (Prostate Cancer)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Histone Deacetylase 2
2. Histone Deacetylase Inhibitors
3. Neuroprotective Agents
4. Cytokines
5. Tubulin
6. Histone Deacetylases (Histone Deacetylase)
7. theasinensin A
8. trichostatin A (A 300)